|
|
BetterLife Pharma Inc
CSE •
Healthcare •
Biotechnology •
Quote as of 09/11/2026 15:59
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeCSE
Market Capitalization51.68 mln
Float116 mln
Earnings Date06/03/2025
Relative Strength
77
/ 100
Strongly outperforming
Key Fundamentals
EPS-0.01
ROIC-151
ROA-780
Interest Cover-10.34
EBITDA, mln-1.73
EV / EBITDA-33.26
EV / EBIT-33.26
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
13.33% |
83
/ 100
 |
| 1 Month |
7.94% |
66
/ 100
 |
| 2 Months |
467% |
99
/ 100
 |
| 6 Months |
580% |
99
/ 100
|
| 1 Year |
240% |
90
/ 100
 |
|
| |
